{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:43:30Z","timestamp":1790959410821,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13048-016-0292-1","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T05:02:34Z","timestamp":1480050154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma"],"prefix":"10.1186","volume":"9","author":[{"given":"Xiao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"issue":"3","key":"292_CR1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","volume":"20","author":"DJ Cheon","year":"2014","unstructured":"Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, et al. A collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer. Clin Cancer Res. 2014;20(3):711\u201323.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"292_CR2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","volume":"233","author":"CA Sherman-Baust","year":"2014","unstructured":"Sherman-Baust CA, Kuhn E, Valle BL, Shih Ie M, Kurman RJ, Wang TL, et al. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. J Pathol. 2014;233(3):228\u201337.","journal-title":"J Pathol"},{"issue":"6","key":"292_CR3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.humpath.2004.01.024","volume":"35","author":"C Faleiro-Rodrigues","year":"2004","unstructured":"Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Ferreira VM, Lopes CS. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Hum Pathol. 2004;35(6):663\u20139.","journal-title":"Hum Pathol"},{"issue":"4","key":"292_CR4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s13277-013-0797-9","volume":"34","author":"R Bhagat","year":"2013","unstructured":"Bhagat R, Premalata CS, Shilpa V, Pallavi VR, Ramesh G, Vijay CR, et al. Altered expression of beta-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma. Tumour Biol. 2013;34(4):2459\u201368.","journal-title":"Tumour Biol"},{"issue":"5","key":"292_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih Ie M, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009;16(5):267\u201382.","journal-title":"Adv Anat Pathol"},{"issue":"8","key":"292_CR6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.pas.0000166367.68459.7d","volume":"29","author":"CJ O\u2019Neill","year":"2005","unstructured":"O\u2019Neill CJ, Deavers MT, Malpica A, Foster H, McCluggage WG. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2\/neu, and C-KIT in high-grade neoplasms. Am J Surg Pathol. 2005;29(8):1034\u201341.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"292_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2007.07.025","volume":"424","author":"Y Numachi","year":"2007","unstructured":"Numachi Y, Yoshida S, Yamashita M, Fujiyama K, Toda S, Matsuoka H, et al. Altered EphA5 mRNA expression in rat brain with a single methamphetamine treatment. Neurosci Lett. 2007;424(2):116\u201321.","journal-title":"Neurosci Lett"},{"issue":"8","key":"292_CR8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00431-013-2008-5","volume":"172","author":"YJ Wu","year":"2013","unstructured":"Wu YJ, Xu MY, Wang L, Sun BL, Gu GX. Analysis of EphA5 receptor in the developing rat brain: an in vivo study in congenital hypothyroidism model. Eur J Pediatr. 2013;172(8):1077\u201383.","journal-title":"Eur J Pediatr"},{"key":"292_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2008.02.047","volume":"1205","author":"PC Mamiya","year":"2008","unstructured":"Mamiya PC, Hennesy Z, Zhou R, Wagner GC. Changes in attack behavior and activity in EphA5 knockout mice. Brain Res. 2008;1205:91\u20139.","journal-title":"Brain Res"},{"issue":"2","key":"292_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2013.08.028","volume":"57","author":"T Yamada","year":"2013","unstructured":"Yamada T, Yuasa M, Masaoka T, Taniyama T, Maehara H, Torigoe I, et al. After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate. Bone. 2013;57(2):343\u201354.","journal-title":"Bone"},{"issue":"2","key":"292_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.visres.2010.09.022","volume":"51","author":"TD Petkova","year":"2011","unstructured":"Petkova TD, Seigel GM, Otteson DC. A role for DNA methylation in regulation of EphA5 receptor expression in the mouse retina. Vision Res. 2011;51(2):260\u20138.","journal-title":"Vision Res"},{"issue":"2","key":"292_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s004410050930","volume":"290","author":"IW Caras","year":"1997","unstructured":"Caras IW. A link between axon guidance and axon fasciculation suggested by studies of the tyrosine kinase receptor EphA5\/REK7 and its ligand ephrin-A5\/AL-1. Cell Tissue Res. 1997;290(2):261\u20134.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"292_CR13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/(SICI)1096-9861(20000124)416:4<540::AID-CNE9>3.0.CO;2-Y","volume":"416","author":"JA St John","year":"2000","unstructured":"St John JA, Tisay KT, Caras IW, Key B. Expression of EphA5 during development of the olfactory nerve pathway in rat. J Comp Neurol. 2000;416(4):540\u201350.","journal-title":"J Comp Neurol"},{"issue":"1","key":"292_CR14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2009.06.007","volume":"41","author":"DY Fu","year":"2010","unstructured":"Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, et al. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer. Hum Pathol. 2010;41(1):48\u201358.","journal-title":"Hum Pathol"},{"issue":"2","key":"292_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12253-009-9221-6","volume":"16","author":"C Giaginis","year":"2010","unstructured":"Giaginis C, Tsourouflis G, Zizi-Serbetzoglou A, Kouraklis G, Chatzopoulou E, Dimakopoulou K, et al. Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma. Pathol Oncol Res. 2010;16(2):267\u201376.","journal-title":"Pathol Oncol Res"},{"key":"292_CR16","doi-asserted-by":"crossref","unstructured":"Gu Y, Li F, Qian N, Chen X, Wang H, Wang J. Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival. J Clin Pathol. 2016;69(5):448-53.","DOI":"10.1136\/jclinpath-2015-203160"},{"issue":"2","key":"292_CR17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ctrv.2014.12.003","volume":"41","author":"C Della Pepa","year":"2015","unstructured":"Della Pepa C, Tonini G, Santini D, Losito S, Pisano C, Di Napoli M, et al. Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy. Cancer Treat Rev. 2015;41(2):136\u201343.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"292_CR18","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/cncr.26618","volume":"118","author":"DC Bodurka","year":"2012","unstructured":"Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, et al. Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer. 2012;118(12):3087\u201394.","journal-title":"Cancer"},{"issue":"3","key":"292_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2559.2007.02912.x","volume":"52","author":"N Singh","year":"2008","unstructured":"Singh N, Ayhan A, Menon U, Chin Aleong JA, Faruqi AZ, Gayther SA, et al. Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systems. Histopathology. 2008;52(3):393\u20135.","journal-title":"Histopathology"},{"key":"292_CR20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12885-015-1025-3","volume":"15","author":"S Li","year":"2015","unstructured":"Li S, Zhu Y, Ma C, Qiu Z, Zhang X, Kang Z, et al. Downregulation of EphA5 by promoter methylation in human prostate cancer. BMC Cancer. 2015;15:18.","journal-title":"BMC Cancer"},{"issue":"11","key":"292_CR21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mc.20763","volume":"50","author":"P Kober","year":"2011","unstructured":"Kober P, Bujko M, Oledzki J, Tysarowski A, Siedlecki JA. Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer. Mol Carcinog. 2011;50(11):846\u201356.","journal-title":"Mol Carcinog"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-016-0292-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T21:08:48Z","timestamp":1657832928000},"score":1,"resource":{"primary":{"URL":"http:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-016-0292-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s13048-016-0292-1","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]},"article-number":"83"}}